Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Radiation pneumonitis and lung fibrosis, Consolidation therapy, Chemoradiation (chemoradiotherapy, CRT), PET/CT and the tags subtype-page, lung.
Shares David Planchard, PD-L1-high non-small-cell lung cancer without a driver mutation, Pemetrexed, EGFR-mutated non-small-cell lung cancer and the tags subtype-page, lung.
Shares Adenocarcinoma of the lung, ALK-positive non-small-cell lung cancer, PD-L1-high non-small-cell lung cancer without a driver mutation, PD-1 / PD-L1 immune checkpoint & T-cell activation and the tags subtype-page, lung.
Shares Consolidation therapy, Hypofractionated radiotherapy, PET/CT, PD-1 / PD-L1 immune checkpoint & T-cell activation and the tags subtype-page, lung.
Shares Adenocarcinoma of the lung, ALK-positive non-small-cell lung cancer, Osimertinib, Pemetrexed and the tags subtype-page, lung.
Shares Interstitial lung disease (ILD) / pneumonitis, ALK-positive non-small-cell lung cancer, Pemetrexed, EGFR-mutated non-small-cell lung cancer and the tags subtype-page, lung.
Shares ALK-positive non-small-cell lung cancer, Pemetrexed, EGFR-mutated non-small-cell lung cancer, Carboplatin and the tags subtype-page, lung.
Shares ALK-positive non-small-cell lung cancer, Pemetrexed, Carboplatin, Small-molecule kinase inhibitors and the tags subtype-page, lung.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.